After participating in this educational activity, attendees should be able to:
1. Recognize the mechanism of action of biologic therapies available for childhood atopic dermatitis.
2. Identify the side effects of biologic therapies available for childhood atopic dermatitis.
3. Restate the efficacy of the biologic therapies for childhood atopic dermatitis.


Richard J. Antaya, MD
Professor of Dermatology, Pediatrics & Nursing
Yale University


Faculty Disclosure

The design and content of Baystate Continuing Interprofessional Education ( CE ) activities support quality improvement in healthcare and provide fair and balanced views of therapeutic options.  Faculty or planner conflicts of interest are resolved before the educational activity.

Dr. Richard Antaya attests that he is currently receiving grant/research support from Leo Pharma for a clinical trial and had received royalty from an advisory board.


Session date: 
03/23/2021 - 8:00am to 9:00am EDT
Webinar Live
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 APA American Psychological Association
    Baystate Health is approved by the American Psychological Association to sponsor continuing education for psychologists. Baystate Health maintains responsibility for this program and its content.
  • 1.00 BCIPE Instructional Hours

Please login or register to take this course.